vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Western Union CO (WU). Click either name above to swap in a different company.

Western Union CO is the larger business by last-quarter revenue ($982.7M vs $962.7M, roughly 1.0× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.7% vs 6.6%, a 1.1% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 0.0%). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs -1.9%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.

ATR vs WU — Head-to-Head

Bigger by revenue
WU
WU
1.0× larger
WU
$982.7M
$962.7M
ATR
Growing faster (revenue YoY)
ATR
ATR
+13.5% gap
ATR
13.5%
0.0%
WU
Higher net margin
ATR
ATR
1.1% more per $
ATR
7.7%
6.6%
WU
Faster 2-yr revenue CAGR
ATR
ATR
Annualised
ATR
2.6%
-1.9%
WU

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ATR
ATR
WU
WU
Revenue
$962.7M
$982.7M
Net Profit
$74.3M
$64.7M
Gross Margin
Operating Margin
11.0%
12.5%
Net Margin
7.7%
6.6%
Revenue YoY
13.5%
0.0%
Net Profit YoY
-26.4%
-47.6%
EPS (diluted)
$1.13
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
WU
WU
Q1 26
$982.7M
Q4 25
$962.7M
$972.0M
Q3 25
$961.1M
$985.3M
Q2 25
$966.0M
$983.6M
Q1 25
$887.3M
$938.7M
Q4 24
$848.1M
$1.0B
Q3 24
$909.3M
$993.4M
Q2 24
$910.1M
$1.0B
Net Profit
ATR
ATR
WU
WU
Q1 26
$64.7M
Q4 25
$74.3M
$114.4M
Q3 25
$127.9M
$139.6M
Q2 25
$111.7M
$122.1M
Q1 25
$78.8M
$123.5M
Q4 24
$100.9M
$385.7M
Q3 24
$100.0M
$264.8M
Q2 24
$90.5M
$141.0M
Gross Margin
ATR
ATR
WU
WU
Q1 26
Q4 25
33.6%
Q3 25
34.7%
Q2 25
34.6%
Q1 25
34.0%
Q4 24
35.0%
Q3 24
34.2%
Q2 24
35.0%
Operating Margin
ATR
ATR
WU
WU
Q1 26
12.5%
Q4 25
11.0%
19.1%
Q3 25
14.2%
20.5%
Q2 25
14.9%
19.6%
Q1 25
12.8%
18.9%
Q4 24
14.2%
17.5%
Q3 24
15.2%
16.6%
Q2 24
13.8%
18.7%
Net Margin
ATR
ATR
WU
WU
Q1 26
6.6%
Q4 25
7.7%
11.8%
Q3 25
13.3%
14.2%
Q2 25
11.6%
12.4%
Q1 25
8.9%
13.2%
Q4 24
11.9%
37.9%
Q3 24
11.0%
26.7%
Q2 24
9.9%
13.8%
EPS (diluted)
ATR
ATR
WU
WU
Q1 26
$0.41
Q4 25
$1.13
$0.36
Q3 25
$1.92
$0.43
Q2 25
$1.67
$0.37
Q1 25
$1.17
$0.36
Q4 24
$1.48
$1.14
Q3 24
$1.48
$0.78
Q2 24
$1.34
$0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
WU
WU
Cash + ST InvestmentsLiquidity on hand
$409.5M
$909.2M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$2.7B
$910.5M
Total Assets
$5.3B
$8.1B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
WU
WU
Q1 26
$909.2M
Q4 25
$409.5M
$1.2B
Q3 25
$264.8M
$947.8M
Q2 25
$169.8M
$1.0B
Q1 25
$136.8M
$1.3B
Q4 24
$226.2M
$1.5B
Q3 24
$327.9M
$1.1B
Q2 24
$223.9M
$1.0B
Total Debt
ATR
ATR
WU
WU
Q1 26
Q4 25
$1.1B
$2.9B
Q3 25
$546.0M
$2.5B
Q2 25
$535.1M
$2.5B
Q1 25
$561.2M
$2.5B
Q4 24
$688.1M
$3.0B
Q3 24
$822.7M
$2.1B
Q2 24
$681.5M
$2.1B
Stockholders' Equity
ATR
ATR
WU
WU
Q1 26
$910.5M
Q4 25
$2.7B
$957.8M
Q3 25
$2.8B
$925.4M
Q2 25
$2.7B
$883.6M
Q1 25
$2.5B
$939.4M
Q4 24
$2.5B
$968.9M
Q3 24
$2.5B
$652.7M
Q2 24
$2.4B
$440.8M
Total Assets
ATR
ATR
WU
WU
Q1 26
$8.1B
Q4 25
$5.3B
$8.3B
Q3 25
$5.1B
$7.8B
Q2 25
$4.9B
$8.0B
Q1 25
$4.5B
$8.3B
Q4 24
$4.4B
$8.4B
Q3 24
$4.6B
$7.7B
Q2 24
$4.5B
$8.0B
Debt / Equity
ATR
ATR
WU
WU
Q1 26
Q4 25
0.43×
3.01×
Q3 25
0.20×
2.70×
Q2 25
0.20×
2.83×
Q1 25
0.22×
2.61×
Q4 24
0.28×
3.04×
Q3 24
0.32×
3.29×
Q2 24
0.28×
4.88×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
WU
WU
Operating Cash FlowLast quarter
$183.7M
$109.0M
Free Cash FlowOCF − Capex
$96.9M
FCF MarginFCF / Revenue
10.1%
Capex IntensityCapex / Revenue
9.0%
4.8%
Cash ConversionOCF / Net Profit
2.47×
1.68×
TTM Free Cash FlowTrailing 4 quarters
$299.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
WU
WU
Q1 26
$109.0M
Q4 25
$183.7M
$135.4M
Q3 25
$177.6M
$260.4M
Q2 25
$126.0M
$-300.0K
Q1 25
$82.7M
$148.2M
Q4 24
$178.2M
$134.0M
Q3 24
$229.3M
$212.1M
Q2 24
$143.6M
$-33.8M
Free Cash Flow
ATR
ATR
WU
WU
Q1 26
Q4 25
$96.9M
$115.5M
Q3 25
$114.3M
$252.7M
Q2 25
$62.5M
$-7.8M
Q1 25
$25.9M
$144.8M
Q4 24
$112.2M
$119.7M
Q3 24
$162.7M
$205.1M
Q2 24
$75.4M
$-38.9M
FCF Margin
ATR
ATR
WU
WU
Q1 26
Q4 25
10.1%
11.9%
Q3 25
11.9%
25.6%
Q2 25
6.5%
-0.8%
Q1 25
2.9%
15.4%
Q4 24
13.2%
11.8%
Q3 24
17.9%
20.6%
Q2 24
8.3%
-3.8%
Capex Intensity
ATR
ATR
WU
WU
Q1 26
4.8%
Q4 25
9.0%
2.0%
Q3 25
6.6%
0.8%
Q2 25
6.6%
0.8%
Q1 25
6.4%
0.4%
Q4 24
7.8%
1.4%
Q3 24
7.3%
0.7%
Q2 24
7.5%
0.5%
Cash Conversion
ATR
ATR
WU
WU
Q1 26
1.68×
Q4 25
2.47×
1.18×
Q3 25
1.39×
1.87×
Q2 25
1.13×
-0.00×
Q1 25
1.05×
1.20×
Q4 24
1.77×
0.35×
Q3 24
2.29×
0.80×
Q2 24
1.59×
-0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

WU
WU

Segment breakdown not available.

Related Comparisons